Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 6, 2012, Pages 1265-1273

  Xaymardan, Munira ^a   Sun, Zhuo ^a   Hatta, Kota ^a   Tsukashita, Masaki ^a   Konecny, Filip ^a   Weisel, Richard D ^a   Li, Ren Ke ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cardiac function; Myocardial infarction; Tissue repair; Uterine cells; Women

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MOTILITY; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INFARCTION; HYSTERECTOMY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TISSUE REPAIR; UTERUS;

ANIMALS; CHEMOKINES; CYTOKINES; FEMALE; HYSTERECTOMY; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; REGENERATION; STEM CELLS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 84860520071     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.03.002     Document Type: Article

References (36)

1. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987, 316:1105-1110.
2. Gordon T., Kannel W.B., Hjortland M.C., McNamara P.M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978, 89:157-161.
3. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976, 85:447-452.
4. O'Meara E., Clayton T., McEntegart M.B., McMurray J.J.V., Pina I.L., Granger C.B., et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007, 115:3111-3120.
5. Piro M., Della Bona R., Abbate A., Biasucci L.M., Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol 2010, 55:1057-1065.
6. Wang M., Crisostomo P., Wairiuko G.M., Meldrum D.R. Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 2006, 290:H2204-H2209.
7. Gierach G.L., Johnson B.D., Bairey Merz C.N., Kelsey S.F., Bittner V., Olson M.B., et al. Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 2006, 47:50S-58S.
8. Vaccarino V., Krumholz H.M., Yarzebski J., Gore J.M., Goldberg R.J. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001, 134:173-181.
9. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006, 7:821-828.
10. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712.
11. Bush T.L., Barrett-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75:1102-1109.
12. Falkeborn M., Persson I., Adami H.O., Bergstrom R., Eaker E., Lithell H., et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992, 99:821-828.
13. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003, 349:523-534.
14. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanik M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
15. Falkeborn M., Schairer C., Naessen T., Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 2000, 53:832-837.
16. Ingelsson E., Lundholm C., Johansson A.L., Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011, 32:745-750.
17. Parker W.H., Broder M.S., Chang E., Feskanich D., Farquhar C., Liu Z., et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 2009, 113:1027-1037.
18. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006, 116:1865-1877.
19. + stem cell survival and engraftment in the infarcted heart. Circulation 2009, 119:2587-2596.
20. Tang X.L., Rokosh G., Sanganalmath S.K., Yuan F., Sato H., Mu J., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121:293-305.
21. Sun Z., Zhang Y., Brunt K.R., Wu J., Li S.H., Fazel S., et al. An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential. Blood 2010, 116:2932-2941.
22. Gargett C.E., Rogers P.A. Human endometrial angiogenesis. Reproduction 2001, 121:181-186.
23. Shafik A., El-Sibai O., Shafik I. Identification of c-kit-positive cells in the uterus. Int J Gynaecol Obstet 2004, 87:254-255.
24. Tsuji S., Yoshimoto M., Takahashi K., Noda Y., Nakahata T., Heike T. Side population cells contribute to the genesis of human endometrium. Fertil Steril 2008, 90:1528-1537.
25. Huang M.L., Tian H., Wu J., Matsubayashi K., Weisel R.D., Li R.K. Myometrial cells induce angiogenesis and salvage damaged myocardium. Am J Physiol Heart Circ Physiol 2006, 291:H2057-H2066.
26. Santamaria X., Massasa E.E., Feng Y., Wolff E., Taylor H.S. Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther 2011, 19(11):2065-2071.
27. Wolff E.F., Gao X.B., Yao K.V., Andrews Z.B., Du H., Elsworth J.D., et al. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J Cell Mol Med 2011, 15:747-755.
28. Itakura E., Odaira K., Yokoyama K., Osuna M., Hara T., Inoue K. Generation of transgenic rats expressing green fluorescent protein in S-100beta-producing pituitary folliculo-stellate cells and brain astrocytes. Endocrinology 2007, 148:1518-1523.
29. Racho El-Akouri R., Kurlberg G., Dindelegan G., Molne J., Wallin A., Brannstrom M. Heterotopic uterine transplantation by vascular anastomosis in the mouse. J Endocrinol 2002, 174:157-166.
30. Vaccarino V., Parsons L., Every N.R., Barron H.V., Krumholz H.M. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999, 341:217-225. for the National Registry of Myocardial Infarction 2 Participants.
31. Palmer J.R., Rosenberg L., Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992, 136:408-416.
32. Onodera N., Tamaki T., Okada Y., Akatsuka A., Aoki D. Identification of tissue-specific vasculogenic cells originating from murine uterus. Histochem Cell Biol 2006, 125:625-635.
33. Winitsky S.O., Gopal T.V., Hassanzadeh S., Takahashi H., Gryder D., Rogawski M.A., et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 2005, 3:e87.
34. Halkos M.E., Zhao Z.Q., Kerendi F., Wang N.P., Jiang R., Schmarkey L.S., et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 2008, 103:525-536.
35. Price M.J., Chou C.-C., Frantzen M., Miyamoto T., Kar S., Lee S., et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 2006, 111:231-239.
36. Hamada H., Kim M.K., Iwakura A., Ii M., Thorne T., Qin G., et al. Estrogen receptors a and b mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 2006, 114:2261-2270.